We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EWBC:NASDAQEast West Bancorp, Inc. Analysis

Data as of 2026-06-18 - not real-time

$126.81

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

East West Bancorp (EWBC) is trading at $126.81, comfortably above its 20‑day SMA ($125.83) and 50‑day SMA ($123.11) while still below the 200‑day SMA ($112.68) trend line, indicating a bullish bias. Technical indicators such as a bullish MACD crossover (line 2.13 vs signal 2.07) and a neutral RSI (53.7) support continued upside, with the price holding above the identified support of $119.49 and approaching the resistance near $136. Fundamentally, the stock trades at a PE of 12.7 versus an industry average of 16.9 and a P/B of 1.93, suggesting it is undervalued. The DCF fair value of $207.91 implies an upside of roughly 8.4%, and the dividend yield of 2.45% with a modest 26% payout ratio points to sustainable income. Market sentiment is extremely bullish, reflected by a Fear & Greed Index reading of 92 (Extreme Greed), and volume is on an increasing trend, adding confidence to the price action. Overall, EWBC combines solid earnings growth (14% revenue growth), strong profitability margins, and a robust cash position, making it an attractive candidate for investors seeking both value and growth exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key SMAs and bullish MACD
  • Undervalued valuation relative to peers and DCF upside
  • Sustainable dividend yield supporting total return

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings growth and high ROE (~16%)
  • Continued dividend sustainability with low payout ratio
  • Gap between market price and DCF fair value indicating upside potential

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust cash position and low leverage enhancing balance‑sheet resilience
  • Long‑term valuation upside of >8% plus attractive dividend income
  • Strategic positioning in US‑Asia trade finance supporting future growth

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin50.00%
P/E Ratio12.7
ROE16.45%
ROA1.75%
P/B Ratio1.9
Op. Cash Flow$1.7B
Industry P/E16.9

Technical Analysis

TrendBullish
RSI53.7
Support$119.49
Resistance$136.00
MA 20$125.83
MA 50$123.11
MA 200$112.68
MACDBullish
VolumeIncreasing
Fear & Greed Index92.14

Valuation

Fair Value$207.91
Target Price$137.44
Upside/Downside8.38%
GradeUndervalued
TypeBlend
Dividend Yield2.45%

Risk Assessment

Beta0.99
Volatility21.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.